Loading people...
Aftab Kherani is a Partner at Aisling Capital, a leading private equity firm focused on investments in the healthcare and life sciences sectors.
Aftab Kherani invests in a wide range of healthcare companies, including those in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services, through his role at Aisling Capital.
Aftab Kherani works as a Partner at Aisling Capital, a prominent private equity firm specializing in healthcare investments.
Aftab Kherani is an Operating Partner at Aisling Capital and the Chief Medical Officer of Ajax Health, based in New York. Before transitioning to venture capital, he worked as an Engagement Manager at McKinsey & Company within its pharmaceutical and private equity practices and served as Chief Resident in Surgery at Duke University Medical Center. He earned his medical degree from the Duke University School of Medicine and completed a post-doctoral research fellowship at Columbia University. Throughout his investment career, Kherani has directed funding and held board seats for numerous life sciences companies, contributing to major exits such as Loxo Oncology's $8 billion acquisition by Eli Lilly and Ajax Health's acquisition by Medtronic. He currently leverages his clinical and strategic expertise to source, evaluate, and manage investments across the biopharma, medical device, and diagnostics sectors.
Aftab Kherani serves as a distinguished Partner at Aisling Capital, a premier private equity firm renowned for its strategic investments within the dynamic healthcare and life sciences industries. At Aisling Capital, Mr. Kherani plays a pivotal role in sourcing, evaluating, and executing investments in companies poised to revolutionize patient care and medical innovation.
His investment focus at Aisling Capital spans a broad spectrum of the healthcare ecosystem, including cutting-edge biotechnology firms, pharmaceutical companies developing novel therapies, medical device manufacturers creating advanced diagnostic and treatment tools, and innovative companies in the diagnostics and healthcare services sectors. Aftab Kherani is dedicated to identifying opportunities that not only promise significant financial returns but also hold the potential to deliver substantial societal impact through scientific advancement and improved health outcomes.
Before ascending to his current position as Partner, Aftab Kherani built a strong foundation in healthcare finance and investment. His career trajectory at Aisling Capital includes prior roles as Vice President and Associate, where he gained extensive experience in private equity deal execution and portfolio management. Prior to joining Aisling Capital, Mr. Kherani honed his financial acumen and industry insights within the healthcare investment banking group at Credit Suisse, a global financial services firm. This experience provided him with a deep understanding of market dynamics, corporate finance strategies, and the unique challenges and opportunities within the healthcare sector.
Academically, Aftab Kherani holds an MBA from Columbia Business School, a testament to his commitment to advanced business strategy and leadership. He also earned a BS in Finance from the New York University Stern School of Business, providing him with a robust analytical framework essential for complex investment decisions. His comprehensive background in finance, coupled with his specialized expertise in healthcare, positions him as a key contributor to Aisling Capital's success and its mission to support transformative life science companies. While specific notable investments are part of the firm's confidential portfolio, Mr. Kherani consistently contributes to the identification and growth of promising ventures that align with Aisling Capital's strategic vision.
